Vetter achieves platinum status as a Best Managed Company

Honorary Senator Udo J. Vetter, Chairman of the Supervisory Board and member of the family of owners (right), and Vetter Managing Director Titus Ottinger (left) at the award ceremony in the Palmengarten Social House in Frankfurt. © Vetter Pharma International GmbH

– Family business impresses again in all four competition areas
– Site development and digitalization as strategic investment priorities
– New skilled workforce potentials and lifelong learning in focus

Vetter, a partner of global pharmaceutical and biotech companies for the manufacturing of life-enhancing medicines, has been awarded the Best Managed Company title for the seventh time. The family business has thus, as the only company in this year's competition, achieved the platinum status anew. The renowned award is presented by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries (BDI) to companies for outstanding performance in leadership and management. The jury evaluates companies based on four value drivers: strategy, productivity, culture and commitment, as well as governance and finances. In 2026, the pharmaceutical service provider receives the award primarily for the consistent further development of its corporate strategy and processes in a globally challenging environment. During a ceremonial award presentation on May 21 at the Palmengarten Society House in Frankfurt, the trophy and certificate were handed over to Vetter.

Strategic foresight, active risk management, and sustainable growth

The jury was particularly impressed by the company's consistent and continuous strategic work: With the successful completion of the current strategy program Vetter NExT 2029, a solid foundation has been laid to develop and finalize a new, forward-looking program this year. The family business also stands out through its clear focus on achieving ambitious climate protection goals. At the same time, the further development of integrated corporate reporting and ongoing risk management enhances the company's ability to act. This enables proactive and reliable action even in times of geopolitical uncertainties and their potential impacts on supply chains, energy supply, and other framework conditions.

"The repeated recognition as a Best Managed Company with this year's achievement of platinum status confirms the strength and resilience of our strategic corporate orientation," says Senator h.c. Udo J. Vetter, Chairman of the Supervisory Board and member of the founding family. "Our sustainable growth is the result of long-term thinking and consistent investments in our product portfolio and the necessary infrastructure. We pursue our goal daily to supply patients worldwide with important medicines and thus contribute to improved quality of life." Vetter CEO Titus Ottinger adds: "Another investment focus for us is the digitalization of our value creation processes. The leverage is significant. Our core claim remains the same: fewer manual interfaces, more seamless data flows, more data integrity – without compromises on compliance. This solidifies our position as a leader in quality and technology and also the long-term trust of our customers in us."

Environmental responsibility and continuous investments in employees

The jury also praised the clearly defined, ambitious climate goals, with which Vetter systematically advances the reduction of its CO2 emissions. The pharmaceutical service provider succeeds in combining ecological responsibility with economic success. Furthermore, the comprehensive commitment to securing skilled workers and employee development was highlighted: With innovative approaches such as the Integrative Entry Program, Vetter unlocks additional workforce potentials and ensures successful qualification, language support, and integration. With the company-wide introduction of the digital learning platform Vetter Learning, the company consciously emphasizes lifelong learning, knowledge transfer, and the continuous development of its employees.

Markus Seiz, head of the Best Managed Companies (BMC) program in Germany at Deloitte Private, emphasizes: "We have been accompanying Vetter for many years and are continually impressed by how intensively and consistently management and employees engage in strategic processes. Moreover, the pharmaceutical service provider is an outstanding example of how the application process itself can serve as a complementary catalyst for the company."